A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

NCT03078478 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1609

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin degludec
DRUG: Insulin glargine

Sponsor

Novo Nordisk A/S